谱尼测试：10月24日召开董事会会议

Group 1 - The core point of the article is that Puni Testing (SZ 300887) held its sixth second board meeting on October 24, 2025, to review the agenda including the proposal for the Q3 2025 report [1] - For the first half of 2025, Puni Testing's revenue composition shows that professional technical services accounted for 98.82%, while other industries contributed 1.18% [1] - As of the report date, Puni Testing has a market capitalization of 4.4 billion yuan [1] Group 2 - The article highlights that the Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year [1] - It discusses the current hot secondary market for biomedicine, contrasting it with the cooling fundraising environment in the primary market [1]